+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5185514
  • Report
  • October 2020
  • Region: North America
  • 48 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
The North America Sclerotherapy Market is expected to witness market growth of 7.2% CAGR during the forecast period (2020-2026).

Sclerotherapy is a type of minimally invasive procedure that are used for the treatment of or varicose veins. This involves injecting sclerosing agents such as detergents, chemicals, and osmotic agents in the vein. Sclerosing agent cause shrinking of the veins thereby reduces the damage and remove appearance of them. The growing patient geriatric population, technological advancements pertaining to venous diseases, increasing incidence of varicose veins, and rising demand minimally invasive procedures are some of the factors that are driving the market. The introduction of foam sclerotherapy, and ultrasound-guided sclerotherapy has allowed practitioners to adopt these procedures for the painful and underlying veins with accuracy and care. Primary varicose veins are a medical condition in which the congestion occurs in the superficial venous system and may result into eczema and stasis dermatitis.

The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.

Though, lack of training for vascular surgeons, expensive treatment procedures for varicose vein, and healthcare reforms in the U.S. and other developed countries are some of the main factors limiting the growth of market. In addition, many challenges are associated with unreliable reimbursement scenario for the varicose vein treatment procedures in the highly competitive market limits the growth of the market.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
By Type
  • Liquid Sclerotherapy
  • Ultrasound Sclerotherapy
  • Foam Sclerotherapy
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sclerotherapy Market, by Agent
1.4.2 North America Sclerotherapy Market, by Type
1.4.3 North America Sclerotherapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Sclerotherapy Market by Agent
3.1 North America Detergents Market by Country
3.2 North America Osmotic Agents Market by Country
3.3 North America Chemical Irritants Market by Country

Chapter 4. North America Sclerotherapy Market by Type
4.1 North America Liquid Sclerotherapy Market by Country
4.2 North America Ultrasound Sclerotherapy Market by Country
4.3 North America Other Type Market by Country

Chapter 5. North America Sclerotherapy Market by Country
5.1 US Sclerotherapy Market
5.1.1 US Sclerotherapy Market by Agent
5.1.2 US Sclerotherapy Market by Type
5.2 Canada Sclerotherapy Market
5.2.1 Canada Sclerotherapy Market by Agent
5.2.2 Canada Sclerotherapy Market by Type
5.3 Mexico Sclerotherapy Market
5.3.1 Mexico Sclerotherapy Market by Agent
5.3.2 Mexico Sclerotherapy Market by Type
5.4 Rest of North America Sclerotherapy Market
5.4.1 Rest of North America Sclerotherapy Market by Agent
5.4.2 Rest of North America Sclerotherapy Market by Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
Note: Product cover images may vary from those shown
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll